Efficacy and safety of interleukin-6 inhibition with ziltivekimab in patients at high risk of atherosclerotic events in Japan (RESCUE-2): A randomized, double-blind, placebo-controlled, phase 2 trial-Reference-Cited by-同舟云学术

Efficacy and safety of interleukin-6 inhibition with ziltivekimab in patients at high risk of atherosclerotic events in Japan (RESCUE-2): A randomized, double-blind, placebo-controlled, phase 2 trial

Published:2023-10 Issue:4 Volume:82 Page:279-285
ISSN:0914-5087
Container-title:Journal of Cardiology
language:en
Short-container-title:Journal of Cardiology

Author:

Wada Yukihiro,Jensen Camilla,Meyer Anna Sina Pettersson,Zonoozi Amir Abbas Mohseni,Honda Hirokazu

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference15 articles.

1. Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease;Herrington;Circ Res,2016

2. Diagnosis and management of atherosclerotic cardiovascular disease in chronic kidney disease: a review;Mathew;Kidney Int,2017

3. Kidney disease as a risk factor for development of cardiovascular disease;Sarnak;Circulation,2003

4. Evaluation of kidney function throughout the heart failure trajectory – a position statement from the Heart Failure Association of the European Society of Cardiology;Mullens;Eur J Heart Fail,2020

5. Inflammation and cardiovascular disease: from mechanisms to therapeutics;Alfaddagh;Am J Cardiol,2020

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging Trends and Innovations in the Treatment and Diagnosis of Atherosclerosis and Cardiovascular Disease: A Comprehensive Review towards Healthier Aging;Pharmaceutics;2024-08-03

2. GWAS breakthroughs: mapping the journey from one locus to 393 significant coronary artery disease associations;Cardiovascular Research;2024-07-29

3. The Emerging Specialty of Cardio-Rheumatology;Current Atherosclerosis Reports;2024-06-24

4. Coronavirus disease 2019 (COVID-19) pandemic and autoimmune rheumatic diseases: Outcomes and prospects;Rheumatology Science and Practice;2024-02-29

5. Clinical and Serological Associations of Subclinical Atherosclerosis in Spondyloarthropathy;Indian Journal of Rheumatology;2024-02-18